ID

16797

Description

Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00151775

Lien

https://clinicaltrials.gov/show/NCT00151775

Mots-clés

  1. 07/08/2016 07/08/2016 -
Téléchargé le

7 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hypertension NCT00151775

Eligibility Hypertension NCT00151775

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient's seated systolic bp (sesbp) will be greater than or equal to 95th percentile for gender and height-for- age, or greater than or equal to 90th percentile if the patient is diabetic, or has glomerular kidney disease, or has a family history of hypertension.
Description

seated systolic blood pressure

Type de données

boolean

Alias
UMLS CUI [1]
C1319893
negative for hepatitis b and c
Description

negative for hepatitis b and c

Type de données

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
negative for hiv
Description

negative for hiv

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient should not have serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial.
Description

Serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
known sensitivity to olmesartan medoxomil
Description

Sensitivity to olmesartan medoxomil

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0386393
taking prohibited medication
Description

prohibited medication

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0683610
consumed greater than 180 mg of caffeine daily
Description

Caffeine consumption

Type de données

boolean

Alias
UMLS CUI [1]
C0948365
malignant hypertension
Description

Malignant hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C0020540
history of congestive heart failure, cardiomyopathy, or obstructive valve disease
Description

congestive heart failure, cardiomyopathy, or obstructive valve disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0878544
UMLS CUI [3,1]
C0018824
UMLS CUI [3,2]
C0549186
renal transplant within the previous 6 months
Description

Renal transplant

Type de données

boolean

Alias
UMLS CUI [1]
C0022671
severe nephritic syndrome not in remission
Description

Nephritic syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0268732

Similar models

Eligibility Hypertension NCT00151775

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
seated systolic blood pressure
Item
the patient's seated systolic bp (sesbp) will be greater than or equal to 95th percentile for gender and height-for- age, or greater than or equal to 90th percentile if the patient is diabetic, or has glomerular kidney disease, or has a family history of hypertension.
boolean
C1319893 (UMLS CUI [1])
negative for hepatitis b and c
Item
negative for hepatitis b and c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
negative for hiv
Item
negative for hiv
boolean
C0019693 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial
Item
patient should not have serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Sensitivity to olmesartan medoxomil
Item
known sensitivity to olmesartan medoxomil
boolean
C0020517 (UMLS CUI [1,1])
C0386393 (UMLS CUI [1,2])
prohibited medication
Item
taking prohibited medication
boolean
C0013227 (UMLS CUI [1,1])
C0683610 (UMLS CUI [1,2])
Caffeine consumption
Item
consumed greater than 180 mg of caffeine daily
boolean
C0948365 (UMLS CUI [1])
Malignant hypertension
Item
malignant hypertension
boolean
C0020540 (UMLS CUI [1])
congestive heart failure, cardiomyopathy, or obstructive valve disease
Item
history of congestive heart failure, cardiomyopathy, or obstructive valve disease
boolean
C0018802 (UMLS CUI [1])
C0878544 (UMLS CUI [2])
C0018824 (UMLS CUI [3,1])
C0549186 (UMLS CUI [3,2])
Renal transplant
Item
renal transplant within the previous 6 months
boolean
C0022671 (UMLS CUI [1])
Nephritic syndrome
Item
severe nephritic syndrome not in remission
boolean
C0268732 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial